134 related articles for article (PubMed ID: 35538691)
1. Extracellular acidosis stimulates breast cancer cell motility through aryl hydrocarbon receptor and c-src kinase activation.
Miret NV; Zárate LV; Erra Díaz F; Leguizamón MA; Pontillo CA; Chiappini FA; Ceballos L; Geffner J; Randi AS
J Cell Biochem; 2022 Jul; 123(7):1197-1206. PubMed ID: 35538691
[TBL] [Abstract][Full Text] [Related]
2. Activation of c-Src/HER1/STAT5b and HER1/ERK1/2 signaling pathways and cell migration by hexachlorobenzene in MDA-MB-231 human breast cancer cell line.
Pontillo CA; García MA; Peña D; Cocca C; Chiappini F; Alvarez L; Kleiman de Pisarev D; Randi AS
Toxicol Sci; 2011 Apr; 120(2):284-96. PubMed ID: 21205633
[TBL] [Abstract][Full Text] [Related]
3. Hexachlorobenzene modulates the crosstalk between the aryl hydrocarbon receptor and transforming growth factor-β1 signaling, enhancing human breast cancer cell migration and invasion.
Miret N; Pontillo C; Ventura C; Carozzo A; Chiappini F; Kleiman de Pisarev D; Fernández N; Cocca C; Randi A
Toxicology; 2016 Jul; 366-367():20-31. PubMed ID: 27519288
[TBL] [Abstract][Full Text] [Related]
4. FRET analysis of protein tyrosine kinase c-Src activation mediated via aryl hydrocarbon receptor.
Dong B; Cheng W; Li W; Zheng J; Wu D; Matsumura F; Vogel CF
Biochim Biophys Acta; 2011 Apr; 1810(4):427-31. PubMed ID: 21145940
[TBL] [Abstract][Full Text] [Related]
5. Aryl hydrocarbon receptor pathway activation enhances gastric cancer cell invasiveness likely through a c-Jun-dependent induction of matrix metalloproteinase-9.
Peng TL; Chen J; Mao W; Song X; Chen MH
BMC Cell Biol; 2009 Apr; 10():27. PubMed ID: 19371443
[TBL] [Abstract][Full Text] [Related]
6. AhR ligands reactivate LINE-1 retrotransposon in triple-negative breast cancer cells MDA-MB-231 and non-tumorigenic mammary epithelial cells NMuMG.
Miret N; Zappia CD; Altamirano G; Pontillo C; Zárate L; Gómez A; Lasagna M; Cocca C; Kass L; Monczor F; Randi A
Biochem Pharmacol; 2020 May; 175():113904. PubMed ID: 32156659
[TBL] [Abstract][Full Text] [Related]
7. Src-mediated aryl hydrocarbon and epidermal growth factor receptor cross talk stimulates colon cancer cell proliferation.
Xie G; Peng Z; Raufman JP
Am J Physiol Gastrointest Liver Physiol; 2012 May; 302(9):G1006-15. PubMed ID: 22361730
[TBL] [Abstract][Full Text] [Related]
8. Aryl hydrocarbon receptor (AhR) agonists increase airway epithelial matrix metalloproteinase activity.
Tsai MJ; Hsu YL; Wang TN; Wu LY; Lien CT; Hung CH; Kuo PL; Huang MS
J Mol Med (Berl); 2014 Jun; 92(6):615-28. PubMed ID: 24469321
[TBL] [Abstract][Full Text] [Related]
9. Invasion and migration of MDA-MB-231 cells are inhibited by block of AhR and NFAT: role of AhR/NFAT1/β4 integrin signaling.
Shadboorestan A; Tarfiei GA; Montazeri H; Sepand MR; Zangooei M; Khedri A; Ostad SN; Ghahremani MH
J Appl Toxicol; 2019 Feb; 39(2):375-384. PubMed ID: 30294794
[TBL] [Abstract][Full Text] [Related]
10. Hexachlorobenzene triggers AhR translocation to the nucleus, c-Src activation and EGFR transactivation in rat liver.
Randi AS; Sanchez MS; Alvarez L; Cardozo J; Pontillo C; Kleiman de Pisarev DL
Toxicol Lett; 2008 Mar; 177(2):116-22. PubMed ID: 18295415
[TBL] [Abstract][Full Text] [Related]
11. Acidic microenvironment induction of interleukin-8 expression and matrix metalloproteinase-2/-9 activation via acid-sensing ion channel 1 promotes breast cancer cell progression.
Nakanishi M; Korechika A; Yamakawa H; Kawabe N; Nakai K; Muragaki Y
Oncol Rep; 2021 Mar; 45(3):1284-1294. PubMed ID: 33650662
[TBL] [Abstract][Full Text] [Related]
12. The dioxin receptor controls β1 integrin activation in fibroblasts through a Cbp-Csk-Src pathway.
Rey-Barroso J; Colo GP; Alvarez-Barrientos A; Redondo-Muñoz J; Carvajal-González JM; Mulero-Navarro S; García-Pardo A; Teixidó J; Fernandez-Salguero PM
Cell Signal; 2013 Apr; 25(4):848-59. PubMed ID: 23333462
[TBL] [Abstract][Full Text] [Related]
13. Hyaluronan-CD44 interaction promotes c-Src-mediated twist signaling, microRNA-10b expression, and RhoA/RhoC up-regulation, leading to Rho-kinase-associated cytoskeleton activation and breast tumor cell invasion.
Bourguignon LY; Wong G; Earle C; Krueger K; Spevak CC
J Biol Chem; 2010 Nov; 285(47):36721-35. PubMed ID: 20843787
[TBL] [Abstract][Full Text] [Related]
14. Aryl hydrocarbon receptor/cytochrome P450 1A1 pathway mediates breast cancer stem cells expansion through PTEN inhibition and β-Catenin and Akt activation.
Al-Dhfyan A; Alhoshani A; Korashy HM
Mol Cancer; 2017 Jan; 16(1):14. PubMed ID: 28103884
[TBL] [Abstract][Full Text] [Related]
15. Simultaneous inhibition of aryl hydrocarbon receptor (AhR) and Src abolishes androgen receptor signaling.
Ghotbaddini M; Cisse K; Carey A; Powell JB
PLoS One; 2017; 12(7):e0179844. PubMed ID: 28671964
[TBL] [Abstract][Full Text] [Related]
16. Activation of the Aryl Hydrocarbon Receptor Leads to Resistance to EGFR TKIs in Non-Small Cell Lung Cancer by Activating Src-mediated Bypass Signaling.
Ye M; Zhang Y; Gao H; Xu Y; Jing P; Wu J; Zhang X; Xiong J; Dong C; Yao L; Zhang J; Zhang J
Clin Cancer Res; 2018 Mar; 24(5):1227-1239. PubMed ID: 29229632
[No Abstract] [Full Text] [Related]
17. Breast cancer stem-like cells are inhibited by a non-toxic aryl hydrocarbon receptor agonist.
Prud'homme GJ; Glinka Y; Toulina A; Ace O; Subramaniam V; Jothy S
PLoS One; 2010 Nov; 5(11):e13831. PubMed ID: 21072210
[TBL] [Abstract][Full Text] [Related]
18. Activation of aryl hydrocarbon receptor signaling by gallic acid suppresses progression of human breast cancer in vitro and in vivo.
Hanieh H; Ibrahim HM; Mohammed M; Alwassil OI; Abukhalil MH; Farhan M
Phytomedicine; 2022 Feb; 96():153817. PubMed ID: 34782204
[TBL] [Abstract][Full Text] [Related]
19. Estrogen receptor α and aryl hydrocarbon receptor independent growth inhibitory effects of aminoflavone in breast cancer cells.
Brinkman AM; Wu J; Ersland K; Xu W
BMC Cancer; 2014 May; 14():344. PubMed ID: 24885022
[TBL] [Abstract][Full Text] [Related]
20. Aryl hydrocarbon receptor-microRNA-212/132 axis in human breast cancer suppresses metastasis by targeting SOX4.
Hanieh H
Mol Cancer; 2015 Sep; 14():172. PubMed ID: 26377202
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
